Discover what's new.

Access the latest news, business developments, company updates, industry trends, events and more.

| By Kelley Gipson

Shoreline Bio expands international distribution

Shoreline Biome has announced partnerships with six international distributors. The distributors will sell the company’s microbiome kits and other products to companies and research organizations in...

| By Kelley Gipson

Tangen awarded 2nd phase re anthrax contract

The U.S. Department of Health and Human Services’ Biomedical Advanced Research and Development Authority (BARDA) awarded Tangen Biosciences, Inc. the second phase of a contract...

| By Kelley Gipson

Digital Health CT accelerator seeks first cohort

A newly created accelerator program for medical technology and digital health startups is accepting applications for its first cohort of companies. The accelerator, a venture...

| By Kelley Gipson

UConn site lets researchers model cell behavior

UConn Health’s Leslie M. Loew, professor of cell biology and computer science and engineering, has received $1.3 million from the National Institutes of Health to...

| By Kelley Gipson

UConn & Yale researchers focus on allergies

Antibodies are large proteins that can grab onto and neutralize disease-causing microorganisms. Sometimes antibodies get confused, and grab onto harmless molecules from things like peanuts...

| By Kelley Gipson

Assembly Biosciences reports Phase 1b dosing

Assembly Biosciences reports the initiation of dosing in a Phase 1b clinical trial to evaluate ABI-M201 (M201) in patients with mildly to moderately active ulcerative...

| By Kelley Gipson

Aeromics founded to control edema

Marc F. Pelletier arrived in New Haven for a postdoctoral fellowship at Yale in 2002, knowing he wanted to form a biotech company “that would...

| By Kelley Gipson

SpringWorks reports progress re neurofibromatosis

SpringWorks Therapeutics reports that the European Commission has granted Orphan Drug Designation for mirdametinib (formerly PD-0325901), an oral, small molecule inhibitor of MEK1 and MEK2,...